Evidence map›Paper›PMID 29354547›Full record

ReviewIntegrated pharmacy research & practice2017

The role of the pharmacist in the management of type 2 diabetes: current insights and future directions.

Jeffery David Hughes, Yosi Wibowo, Bruce Sunderland, Kreshnik Hoti

Registry-linked trialAbstract readReview
In one paragraph

Review in Integrated pharmacy research & practice, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03752567 ("The Community Pharmacist and the Case Management of Diabetic Patient" - No Profit Observational Study on the Role of the Community Pharmacist and the "Pharmacy of the Services" in the Diabetic Patient Case Management), which is not on this map. Cited by 24 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03752567 completednot on this mapstarted 2018, after this paper: background citation

"The Community Pharmacist and the Case Management of Diabetic Patient" - No Profit Observational Study on the Role of the Community Pharmacist and the "Pharmacy of the Services" in the Diabetic Patient Case Management

TypeobservationalSponsorFarmacia La Regina s.r.l.Ran2018 to 2019Enrolled40ConditionsDiabetes Mellitus, Type 2ArmsFollow up
3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Management of Non-Communicable Diseases in Kosovo: A Scoping Review.International journal of environmental research and public health · 2023
    Article
  11. Review
  12. Polish Patients' Needs and Opinions about the Implementation of Pharmaceutical Care in Diabetes.International journal of environmental research and public health · 2023
    Article
  13. Article
  14. Article
  15. Article
  16. Management of type 2 diabetes with oral semaglutide: Practical guidance for pharmacists.American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists · 2021
    Article
  17. Article
  18. Diabetes, Therapeutic Inertia, and Patients' Medication Experience.Diabetes spectrum : a publication of the American Diabetes Association · 2020
    Article
  19. Article
  20. Pharmacists' Attitudes and Role in Diabetes Management in Bosnia and Herzegovina.Medical archives (Sarajevo, Bosnia and Herzegovina) · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jeffery David HughesSchool of Pharmacy, Curtin University, Perth, WA, Australia.
Yosi WibowoCentre for Medicines Information and Pharmaceutical Care (CMIPIC), Faculty of Pharmacy, Universitas Surabaya, Surabaya, Indonesia.
Bruce SunderlandSchool of Pharmacy, Curtin University, Perth, WA, Australia.
Kreshnik HotiSchool of Pharmacy, Curtin University, Perth, WA, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Type 2 diabetes is a chronic disease occurring in ever increasing numbers worldwide. It contributes significantly to the cost of health globally; however, its management remains in the most part less than optimal. Patients must be empowered to self-manage their disease, and they do this in partnership with health care professionals. Whilst the traditional role of the pharmacist has been centered around the supply of medicines and patient counseling, there is an evergrowing body of evidence that pharmacists, through a range of extended services, may contribute positively to the clinical and humanistic outcomes of those with diabetes. Further, these services can be delivered cost-effectively. This paper provides a review of the current evidence supporting the role of pharmacists in diabetes care, whilst providing a commentary of the future roles of pharmacists in this area.

Indexed as

benefitscost-effectivenessglycemic controlinterventionsoutcomespharmacy

Identifiers

PMID29354547
PMCPMC5774315

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.